Trials / Unknown
UnknownNCT05739916
Phamacokinetics and Safety Profiles of DA-1229_01 5/1000mg in Healthy Subjects at Fed State
An Open Label, Randomized, Single Dose, Cross-over ,Two-group Study to Evaluate the Pharmacokinetics and Safety of DA-1229_01 5/1000mg in Healthy Subjects at Fed State
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 34 (estimated)
- Sponsor
- Dong-A ST Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Accepted
Summary
This Phase I clinical study is to evaluate the safety/tolerability and pharmacokinetics of DA-1229\_01(5/1000 mg x1 tablets) at fed state.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DA-1229_01 5/1000mg (Before) | single dose administration (one tablet once a day) |
| DRUG | DA-1229_01 5/1000mg (After) | single dose administration (one tablet once a day) |
Timeline
- Start date
- 2023-03-30
- Primary completion
- 2023-04-28
- Completion
- 2023-04-28
- First posted
- 2023-02-22
- Last updated
- 2023-02-22
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05739916. Inclusion in this directory is not an endorsement.